Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-kappaB. (Q40134868)

17 September 2017

Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-kappaB. (English)

1 reference

17 September 2017

0 references

1 reference

1 reference

nucleoprotein [SARS-Cov]

0 references

2

Kailang Wu

1 reference

17 September 2017

7

Jianguo Wu

1 reference

17 September 2017

Xue Zhang

1

1 reference

17 September 2017

Di Wang

3

1 reference

17 September 2017

Xin Yue

4

1 reference

17 September 2017

Degui Song

5

1 reference

17 September 2017

Ying Zhu

6

1 reference

17 September 2017

language of work or name

English

0 references

publication date

9 May 2007

1 reference

17 September 2017

12

1 reference

inferred from page(s)

published in

Virology

1 reference

17 September 2017

365

1 reference

17 September 2017

2

1 reference

17 September 2017

324-335

1 reference

IL-6 and NF-IL6 in acute-phase response and viral infection

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Dynamic shuttling of nuclear factor kappa B between the nucleus and cytoplasm as a consequence of inhibitor dissociation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Antibody detection of SARS-CoV spike and nucleocapsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Molecular biology and immunology of interleukin-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Patient data, early SARS epidemic, Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Molecular and cellular biology of interleukin-6 and its receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Activation of NF-kappaB by the full-length nucleocapsid protein of the SARS coronavirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Activation of interleukin-6 gene expression through the NF-kappa B transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

The Genome sequence of the SARS-associated coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

The pathophysiologic roles of interleukin-6 in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

The severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

The structure analysis and antigenicity study of the N protein of SARS-CoV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Isolation of virus from a SARS patient and genome-wide analysis of genetic mutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

Interleukin-6 in biology and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

7 January 2021

inferred from DOI database lookup

An amino-terminal domain of the Sendai virus nucleocapsid protein is required for template function in viral RNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.04.009

7 January 2021

inferred from DOI database lookup

Spike protein of SARS-CoV stimulates cyclooxygenase-2 expression via both calcium-dependent and calcium-independent protein kinase C pathways

1 reference

12 December 2020

Analysis of multimerization of the SARS coronavirus nucleocapsid protein

1 reference

12 December 2020

NF-IL6 and NF-kappa B in cytokine gene regulation

1 reference

12 December 2020

Bovine coronavirus nucleocapsid protein processing and assembly

1 reference

12 December 2020

Interleukin-6: an overview

1 reference

12 December 2020

Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens

1 reference

12 December 2020

10.1016/J.VIROL.2007.04.009

Identifiers

DOI

1 reference

17 September 2017

1 reference